Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab). [electronic resource] by
- Rummel, M
- Kim, T M
- Aversa, F
- Brugger, W
- Capochiani, E
- Plenteda, C
- Re, F
- Trask, P
- Osborne, S
- Smith, R
- Grigg, A
Producer: 20170502
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. [electronic resource] by
- Kim, T M
- Benedict, W F
- Xu, H J
- Hu, S X
- Gosewehr, J
- Velicescu, M
- Yin, E
- Zheng, J
- D'Ablaing, G
- Dubeau, L
Producer: 19940314
In:
Cancer research vol. 54
Availability: No items available.
|
|
16.
|
|
|
17.
|
A small subunit processome protein promotes cancer by altering translation. [electronic resource] by
- Yang, H W
- Kim, T-M
- Song, S S
- Menon, L
- Jiang, X
- Huang, W
- Black, P M
- Park, P J
- Carroll, R S
- Johnson, M D
Producer: 20151110
In:
Oncogene vol. 34
Availability: No items available.
|
|
18.
|
|
|
19.
|
|
|
20.
|
Gene expression signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinib. [electronic resource] by
- Kim, T-M
- Ha, S-A
- Kim, H K
- Yoo, J
- Kim, S
- Yim, S-H
- Jung, S-H
- Kim, D-W
- Chung, Y-J
- Kim, J W
Producer: 20121002
In:
Blood cancer journal vol. 1
Availability: No items available.
|